QuiVad

Home / United Kingdom / Sartorius Stedim Biotech

Sartorius Stedim Biotech

Short position disclosed on September 21, 2026.

Follow

Since 13 July 2026 this regulator publishes an aggregated total per company and no longer names the funds. Positions disclosed before that date remain nominative.

Evolution of the disclosed total

0%1%2%3%
Jul 24Aug 9Aug 25Sep 10
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Aggregated total2.33%+1.52 ptSeptember 21, 2026

In the United States SDMHF (OTC): 32,714 shares sold short on August 31, 2026. FINRA names no fund.

On the other side: the funds that hold Sartorius Stedim Biotech Titelia

Follow by RSS

Get the moves on Sartorius Stedim Biotech by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

35 disclosures on record for this share.
DateFund% of capitalEnd of publication
September 21, 2026Aggregated total2.33%still open
September 14, 2026Aggregated total2.13%September 21, 2026
September 9, 2026Aggregated total2.33%September 14, 2026
September 3, 2026Aggregated total2.13%September 9, 2026
August 31, 2026Aggregated total1.93%September 3, 2026
August 18, 2026Aggregated total1.82%August 31, 2026
August 6, 2026Aggregated total1.72%August 18, 2026
July 27, 2026Aggregated total1.52%August 6, 2026
July 24, 2026Aggregated total1.72%July 27, 2026
July 13, 2026Aggregated total1.52%July 24, 2026
July 8, 2026Aggregated total0.81%July 13, 2026
May 19, 2026AQR Capital Management, LLC0.49%May 21, 2026
May 13, 2026AQR Capital Management, LLC0.50%May 21, 2026
July 18, 2025AQR Capital Management, LLC0.49%July 22, 2025
May 7, 2025AQR Capital Management, LLC0.50%July 22, 2025
January 24, 2025AQR Capital Management, LLC0.49%January 28, 2025
January 17, 2025AQR Capital Management, LLC0.50%January 28, 2025
December 6, 2024Qube Research & Technologies Limited0.01%December 10, 2024
December 5, 2024Qube Research & Technologies Limited0.50%December 10, 2024
December 4, 2024Qube Research & Technologies Limited0.49%December 6, 2024
December 3, 2024Qube Research & Technologies Limited0.50%December 6, 2024
November 29, 2024Qube Research & Technologies Limited0.49%December 3, 2024
November 28, 2024Qube Research & Technologies Limited0.50%December 3, 2024
November 27, 2024Qube Research & Technologies Limited0.49%November 29, 2024
November 20, 2024Qube Research & Technologies Limited0.50%November 29, 2024
October 29, 2024Qube Research & Technologies Limited0.49%October 31, 2024
September 19, 2024Qube Research & Technologies Limited0.50%October 31, 2024
September 16, 2024Qube Research & Technologies Limited0.49%September 18, 2024
August 23, 2024Qube Research & Technologies Limited0.50%September 18, 2024
August 22, 2024Qube Research & Technologies Limited0.49%August 26, 2024
August 16, 2024Qube Research & Technologies Limited0.50%August 26, 2024
July 12, 2024AQR Capital Management, LLC0.49%July 16, 2024
April 24, 2024AQR Capital Management, LLC0.50%July 16, 2024
November 16, 2023AQR Capital Management, LLC0.49%November 20, 2023
November 3, 2023AQR Capital Management, LLC0.50%November 20, 2023

Download 35 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Sartorius Stedim Biotech, source FCA, data as at September 21, 2026, https://www.quivad.com/action/sartorius-stedim-biotech